Delivery Order SPE2DB25D7067-SPE2DB25FSVPN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,652.21 to AmerisourceBergen Drug Corp for IPOL vial 5ML, a poliomyelitis vaccine product. The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, is a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a competitive procurement action under an existing contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,677.88 to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for a 5mL vial of Ipol (polio vaccine) on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,870.10 on August 4, 2025, for the supply of IPOL Vial 5ML pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency (DLA) awarded a $34,902.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for IPOL Vial 5ML pharmaceutical products on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and extending through December 2026. The delivery will be performed in...
- The Defense Logistics Agency awarded a $79,113.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561373729 IPOL vials (5ml each). The place of performance is Conshohocken, Pennsylvania. The order runs from June 29, 2023 through June 30, 2023. DLA utilizes indefinite-delivery/indefinite-quantity contracts to supply medical materiel to all branches of the U.S. military. This delivery order was placed under one such contract vehicle to procure a specific quantity of...
- This delivery order, valued at $132,136, was awarded on July 21, 2025, to AmerisourceBergen Drug Corp for supply of Ipol vial 5ML pharmaceutical products. The contract, which is not set-aside and was competitively awarded, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. The Defense Logistics Agency (DLA), which manages the federal medical supply chain, funded this award under firm fixed-price...
- The Defense Logistics Agency Troop Support Medical awarded a $273,510 firm fixed price delivery order to Amerisourcebergen Drug Corporation for IPOL vials. The order is for 4561322355 5mL vials of IPOL to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 26, 2023. Amerisourcebergen will provide the vials in support of the Defense Logistics Agency's medical supply chain initiatives. No subcontractors or set aside designations were identified. The delivery order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of pharmaceutical products, specifically IPOL VIAL 5ML. The contract has a ceiling value of $1,067.35 and a total performance period through August 13, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by defense and civilian agencies...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,645.16, is for the delivery of IPOL VIAL 5ML pharmaceutical products. It is a firm fixed-price contract with a period of performance through May 1, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVPNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals, vaccines, and medical supplies to support military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen fulfills essential vaccine and medication requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/18/25 |